The use of the Dutch version of the Movement Specific Reinvestment Scale (MSRS) in rehabilitation

The use of the Dutch version of the Movement Specific Reinvestment Scale (MSRS) in rehabilitation - The Movement Specific Reinvestment Scale in rehabilitation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33813

Enrollment

130

Registered

2009-03-24

Start date

2009-01-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CVA Stroke

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participants have to meet following selection criteria: a) clinically diagnosed stroke, b) Age > 18 years c) Sufficient cognitive level and communication skills to fill in the questionnaires (support in writing or reading is allowed) ;Addition for amendment : Only patients who are able to walk independently (Functional Ambulation Category >= 3) will be asked to participate in the additional test.

Exclusion criteria

Exclusion criteria: Sever additional impairments prior to stroke

Design outcomes

Primary

Measure	Time frame
Measuring points in part 1 are at entry in the study and three weeks later. In Part 2 measuring points are at entry (baseline- T0) and after 3, 6 and 9 weeks. In both parts of the study the following characteristics will be collected: age, gender, brain lesion site, co-morbidities or complications. The primary outcome is the Movement Specific Reinvestment Scale. Additional test (amendment): Degree of which a participants performs worse during the stressfull situation (compared to the trainings situation). This will be operationalised by: numbers of falls/stumblings, number of times touching an obstacle, times of freezing (the times that the patient stops walking will be counted).	—

Measure

Time frame

Measuring points in part 1 are at entry in the study and three weeks later. In Part 2 measuring points are at entry (baseline- T0) and after 3, 6 and 9 weeks. In both parts of the study the following characteristics will be collected: age, gender, brain lesion site, co-morbidities or complications. The primary outcome is the *Movement Specific Reinvestment Scale*. Additional test (amendment): Degree of which a participants performs worse during the stressfull situation (compared to the trainings situation). This will be operationalised by: numbers of falls/stumblings, number of times touching an obstacle, times of freezing (the times that the patient stops walking will be counted).

—

Secondary

Measure	Time frame
As additional measurements on functional outcome are used: the Rivermead Mobility Index (part 1 and 2) and the Barthel Index (part2). To control for confounding, in part 2 the Cognitive Log and the Hospital Anxiety and Depression Scale are used. Addiotional test (amendment): Both the patients and independent rater will be asked to judge the quality of the walking on a 10 point Likert scale.	—

Countries

Netherlands

Outcome results